EUVIMEDEUVIMED entdecken
Crossref

Sakuranin Is a Novel Anti‐Inflammatory Agent Targeting TLR4–NF‐κB Signaling Pathways

Jayasingha Arachchige Chathuranga Chanaka Jayasingha, Kyoung Tae Lee, Cheng-Yun Jin, Yung Hyun Choi, Chang Soo Lee, Gi-Young Kim iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202501167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Jayasingha Arachchige Chathuranga Chanaka Jayasingha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Marine Life Science, Jeju National University, Jeju, Republic of Korea. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, NF-kappa B, Signal Transduction, Anti-Inflammatory Agents. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sakuranin (SKR) is naturally occurring compound known for its anti‐inflammatory and antioxidant activities; however, its precise molecular mechanisms in modulating inflammation through toll‐like receptor 4 (TLR4) signaling remain unclear. This study investigates the anti‐inflammatory effects of SKR in lipopolysaccharide (LPS)‐stimulated RAW 264.7 macrophages and zebrafish larvae, focusing on the TLR4–nuclear factor‐kappa B (NF‐κB) signaling pathway. SKR significantly inhibited the production of nitric oxide (NO), prostaglandin E 2 (PGE 2 ), interleukin‐12 (IL‐12), and tumor necrosis factor‐alpha (TNF‐α), while downregulating the expression of inducible NO synthase (NOS2) and cyclooxygenase‐2 (COX2) at both transcriptional and translational levels. In vivo, SKR reduced LPS‐induced mortality, restored cardiac function, and attenuated immune cell infiltration in zebrafish larvae, further underscoring its systemic anti‐inflammatory effects. Mechanistic studies revealed that SKR inhibited NF‐κB nuclear translocation and directly interacted with the TLR4/myeloid differentiation factor 2 (MD2) complex, thereby disrupting LPS–TLR4 signaling. Molecular docking and colocalization analyses confirmed that SKR directly binds TLR4, potentially interfering with LPS recognition and downstream pro‐inflammatory signaling activation. Collectively, these findings highlight SKR as a potent modulator of TLR4‐mediated inflammation, offering promising therapeutic potential for inflammatory disorders. Further investigations into its pharmacokinetics, bioavailability, and long‐term efficacy in chronic inflammatory conditions are warranted to support its clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4NF-kappa BSignal TransductionAnti-Inflammatory AgentsAnimalsZebrafishMiceLipopolysaccharidesRAW 264.7 CellsNitric OxideMolecular Docking SimulationDinoprostoneMolecular StructureStructure-Activity RelationshipDose-Response Relationship, Drug

Stichwörter der Autor:innen

anti‐inflammationnuclear factor‐kappa B (NF‐κB)sakuranintoll‐like receptor 4/myeloid differentiation factor 2 (TLR4/MD2)

Substanzen

Toll-Like Receptor 4NF-kappa BLipopolysaccharidesNitric OxideAnti-Inflammatory AgentsDinoprostone

Autor:innen und Institutionen

  • Department of Marine Life Science, Jeju National University, Jeju, Republic of Korea.
  • Forest Microbiology and Application Division, National Institute of Forest Science, Suwon, Republic of Korea.
  • Key Laboratory of Advanced Technology for Drug Preparation, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Biochemistry, College of Korean Medicine, Dong-Eui University, Busan, Republic of Korea.
  • Biological Resources Research Department, Nakdonggang National Institute of Biological Resources, Sangju, Republic of Korea.

ORCID-Profile: Gi-Young Kim

Zitieren

APA

Jayasingha, J. A. C. C., Lee, K. T., Jin, C. Y., Choi, Y. H., Lee, C. S., & Kim, G. Y. (2025). Sakuranin Is a Novel Anti‐Inflammatory Agent Targeting TLR4–NF‐κB Signaling Pathways. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501167

Vancouver

Jayasingha JACC, Lee KT, Jin CY, Choi YH, Lee CS, Kim GY. Sakuranin Is a Novel Anti‐Inflammatory Agent Targeting TLR4–NF‐κB Signaling Pathways. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501167

BibTeX
@article{Jayasingha2025,
  author = {Jayasingha, Jayasingha Arachchige Chathuranga Chanaka and Lee, Kyoung Tae and Jin, Cheng-Yun and Choi, Yung Hyun and Lee, Chang Soo and Kim, Gi-Young},
  title = {Sakuranin Is a Novel Anti‐Inflammatory Agent Targeting TLR4–NF‐κB Signaling Pathways},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202501167}
}
Kostenlos starten →